Fundraising Fox

electroCore, Inc.

NASDAQ: ECOR

Basking Ridge, US · Delaware corporation · 3 known investors

electrocore.com ↗

electroCore develops non-invasive vagus nerve stimulation (nVNS) technology to deliver bioelectronic medicine for treating various patient conditions. The company manufactures proprietary medical devices, including gammaCore, to stimulate the vagus nerve for health and wellness applications.

BiotechDigital HealthHealthtechMedical Devicesin /660025@electroCoreVNS

Founders & leadership

BP
Brian PosnerExecutive Officer
DS
Daniel S. GoldbergerExecutive Officer, Director
RT
Reese TerryDirector
PS
Peter StaatsDirector
JE
JP ErricoExecutive Officer
TM
Trevor MoodyDirector
JT
Jim TullisDirector
KT
Kathryn TheofilosDirector
FA
Frank AmatoExecutive Officer
DR
David RubinDirector
PC
Peter CuneoDirector
JA
Julie A. GoldsteinDirector

Investors · 3

Foothill VenturesLos Altos · $100K – $10M
Tullis Health InvestorsPalm Beach Gardens · $500K – $10Mvia John Tullis · led
TullisreportedPalm Beach Gardens

Reported raises · per SEC filings

Form D private placements
▶Undisclosed amountofferedApr 2026 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas M. PattonDirector
  • John P. GandolfoDirector
  • Michael FoxExecutive Officer
  • Joshua LevExecutive Officer
  • Elena BonfiglioliDirector
  • Julie Ann GoldsteinDirector
  • Thomas J. ErricoDirector
  • Patricia WilberDirector
  • James C. TheofilosDirector
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedOct 2025 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas J. ErricoDirector
  • Joshua LevExecutive Officer
  • Patricia WilberDirector
  • Thomas M. PattonDirector
  • Elena BonfiglioliDirector
  • James C. TheofilosDirector
  • John P. GandolfoDirector
  • Daniel S. GoldbergerExecutive Officer, Director
  • Julie Ann GoldsteinDirector
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedOct 2025 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Patricia WilberDirector
  • Daniel S. GoldbergerExecutive Officer, Director
  • Julie Ann GoldsteinDirector
  • Joshua LevExecutive Officer
  • Thomas J. ErricoDirector
  • Elena BonfiglioliDirector
  • James C. TheofilosDirector
  • Thomas M. PattonDirector
  • John P. GandolfoDirector
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedSep 2025 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua LevExecutive Officer
  • Patricia WilberDirector
  • John P. GandolfoDirector
  • Thomas M. PattonDirector
  • Julie Ann GoldsteinDirector
  • James C. TheofilosDirector
  • Elena BonfiglioliDirector
  • Thomas J. ErricoDirector
  • Daniel S. GoldbergerExecutive Officer, Director
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedNov 2024 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas M. PattonDirector
  • Peter CuneoDirector
  • Charles S. TheofilosDirector
  • Daniel S. GoldbergerExecutive Officer, Director
  • John P. GandolfoDirector
  • Joshua LevExecutive Officer
  • Patricia WilberDirector
  • Thomas J. ErricoDirector
  • Julie A. GoldsteinDirector
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedAug 2024 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter CuneoDirector
  • Brian PosnerExecutive Officer
  • Julie A. GoldsteinDirector
  • Thomas M. PattonDirector
  • Daniel S. GoldbergerExecutive Officer, Director
  • Thomas J. ErricoDirector
  • John P. GandolfoDirector
  • Patricia WilberDirector
  • Charles S. TheofilosDirector
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.8MraisedJun 2024 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Patricia WilberDirector
  • Julie A. GoldsteinDirector
  • Brian PosnerExecutive Officer
  • Thomas J. ErricoDirector
  • Charles S. TheofilosDirector
  • Daniel S. GoldbergerExecutive Officer, Director
  • Thomas M. PattonDirector
  • Peter CuneoDirector
  • John P. GandolfoDirector
Offering amount
$7.8M
Amount sold
$7.8M
Finders' fees
$17.5K
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedMay 2024 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian PosnerExecutive Officer
  • Peter CuneoDirector
  • Daniel S. GoldbergerExecutive Officer, Director
  • John P. GandolfoDirector
  • Thomas J. ErricoDirector
  • Charles S. TheofilosDirector
  • Thomas M. PattonDirector
  • Julie A. GoldsteinDirector
  • Patricia WilberDirector
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.